TrialPain medicine (Malden, Mass.)2017

A Phase 2b, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.

Lynn R Webster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.